Sam Tsimikas/X
Aug 23, 2025, 08:14
Sam Tsimikas: NAFCS Score as a Diagnostic Tool for Familial Chylomicronemia Syndrome in Clinical Practice
Sam Tsimikas, Professor of Medicine at the University of California, San Diego, shared a post on X:
“A new paper is out in Lipid Journal validating the NAFCS score for patients with FCS (Familial Chylomicronemia Syndrome- i.e milky plasma) using the Balance genetic data. It will be an alternative method to make the diagnosis of FCS clinically.”
Read the full paper here.
Article: Brief communication: Strong concordance of the North American Familial Chylomicronemia Syndrome Score with a positive genetic diagnosis in patients from the Balance study
Authors: Alan S. Brown, Philippe Moulin, Andrew Dibble, Veronica J. Alexander, Lu Li, Daniel Gaudet, Joseph L. Witztum, Sotirios Tsimikas, Robert A.

Stay updated with Hemostasis Today.
Alan S. Brown
Andrew Dibble
Cardiometabolic Health
Chylomicronemia Syndrome
Clinical Validation
Daniel Gaudet
FCS
Genetic Diagnosis
Health
Hematology
Hemostasis Today
Joseph L. Witztum
Lipid Research
LipidJournal
Lu Li
Medicine
NAFCS
Philippe Moulin
Rare Disorders
Robert A.
Sotirios Tsimikas
Veronica J. Alexander
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow
-
Apr 12, 2026, 17:33Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
-
Apr 12, 2026, 17:32Bastu Odoka: Same Blood Group Does Not Guarantee Compatibility
-
Apr 12, 2026, 17:31Jack Hadfield: SARS-CoV-2–Associated Lasting Mitochondrial Injury in Cardiomyocytes